NCT06648018

Brief Summary

The primary aim of the current study is to evaluate the effects of dietary nutritional advice with regards to iron rich food sources or a daily oral supplement of 100 mg ferrous iron succinate in 80 menstruating, healthy women aged 20-40 years for 8 weeks. The study will use a randomized controlled non-blinded design, and 80 healthy women aged 20-40 years whom regularly exercise will be included. Data collection will be made through online, standardized forms using the digital platform REDCap 13.1.28 (Vanderbilt University, Nashville, TN, USA). Study personnel will register laboratory and body weight results through the same system. Participants will be randomized 1:1 to either follow written dietary recommendations to increase their dietary iron intake, or to use a daily oral supplement of 100 mg of iron succinate. Study parameters are blood tests (fasting blood samples will be collected by a licensed laboratory: serum iron, serum transferrin, serum transferrin saturation, serum ferritin, and serum soluble transferrin receptor, blood status (hemoglobin, MCV, MCH, MCHC, thrombocytes, leukocytes), and plasma high-sensitivity C-reactive protein (hsCRP) and Body height and weight as well as questionnaires.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 15, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

October 15, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 18, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2025

Completed
Last Updated

October 18, 2024

Status Verified

October 1, 2024

Enrollment Period

2 months

First QC Date

September 15, 2024

Last Update Submit

October 11, 2024

Conditions

Keywords

nutritionexerciseironwell being

Outcome Measures

Primary Outcomes (1)

  • Ferritin blood test

    Change (increase) in serum ferritin levels.

    From enrollment to end of test period, 8 weeks.

Secondary Outcomes (2)

  • Changes in measures of hemoglobin

    From enrollment to end of test period, 8 weeks.

  • Sense of well being and subjective sense of health

    From enrollment to end of test period, 8 weeks.

Study Arms (2)

Nutritional information

ACTIVE COMPARATOR

Written information about food with high iron content.

Behavioral: Nutritional information

100mg iron-succinate per day as a pill.

EXPERIMENTAL

Participants get 56 pills of 100mg iron-succinate to take one/day for 8 weeks.

Dietary Supplement: Iron-succinate

Interventions

Written nutritional information about food with high content of iron.

Nutritional information
Iron-succinateDIETARY_SUPPLEMENT

100 mg of Iron-succinate per day.

100mg iron-succinate per day as a pill.

Eligibility Criteria

Age20 Years - 40 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsWomen who are menstruating. This is a trial of potentially low ferritin levels in menstruating women.
Healthy VolunteersNo
Age GroupsAdult (18-64)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine and Health Sciences Linköping University

Linköping, 58185, Sweden

Location

MeSH Terms

Conditions

Motor Activity

Interventions

ferrous succinate

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • Fredrik H Nyström, MD PhD Professor

    Linkoeping University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD PhD full professor, senior consultant in internal medicine

Study Record Dates

First Submitted

September 15, 2024

First Posted

October 18, 2024

Study Start

October 15, 2024

Primary Completion

December 1, 2024

Study Completion

January 1, 2025

Last Updated

October 18, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

For ethical reasons such data will not be shared.

Locations